{"log_id": 5246187415693099509, "direction": 0, "words_result_num": 77, "words_result": [{"probability": {"variance": 2.6e-05, "average": 0.996238, "min": 0.980315}, "location": {"width": 254, "top": 97, "height": 26, "left": 130}, "words": "核准日期:2007年04月22日"}, {"probability": {"variance": 5e-06, "average": 0.998164, "min": 0.991288}, "location": {"width": 255, "top": 128, "height": 24, "left": 130}, "words": "修改日期:2010年10月01日"}, {"probability": {"variance": 0.011966, "average": 0.694616, "min": 0.571664}, "location": {"width": 75, "top": 122, "height": 33, "left": 1003}, "words": "飞章盘"}, {"probability": {"variance": 0, "average": 0.863027, "min": 0.863027}, "location": {"width": 72, "top": 164, "height": 30, "left": 365}, "words": " CSF"}, {"probability": {"variance": 2e-06, "average": 0.998599, "min": 0.995273}, "location": {"width": 643, "top": 212, "height": 49, "left": 296}, "words": "重组人粒细胞刺激因子注射液说明书"}, {"probability": {"variance": 1e-06, "average": 0.998959, "min": 0.995818}, "location": {"width": 416, "top": 269, "height": 30, "left": 394}, "words": "请仔细阅读说明书并在医师指导下使用"}, {"probability": {"variance": 0, "average": 0.999873, "min": 0.999651}, "location": {"width": 82, "top": 312, "height": 23, "left": 139}, "words": "药品名称"}, {"probability": {"variance": 1.9e-05, "average": 0.997491, "min": 0.982681}, "location": {"width": 352, "top": 337, "height": 26, "left": 129}, "words": "通用名称:重组人粒细胞刺激因子注射液"}, {"probability": {"variance": 6e-06, "average": 0.99861, "min": 0.992968}, "location": {"width": 138, "top": 361, "height": 23, "left": 129}, "words": "商品名称:瑞白"}, {"probability": {"variance": 0, "average": 0.9995, "min": 0.998734}, "location": {"width": 79, "top": 387, "height": 22, "left": 130}, "words": "英文名称"}, {"probability": {"variance": 0.003814, "average": 0.936098, "min": 0.874338}, "location": {"width": 36, "top": 389, "height": 17, "left": 316}, "words": " nt H"}, {"probability": {"variance": 0.001183, "average": 0.953608, "min": 0.919214}, "location": {"width": 115, "top": 389, "height": 16, "left": 399}, "words": " Granulocyte C"}, {"probability": {"variance": 3.2e-05, "average": 0.996124, "min": 0.985189}, "location": {"width": 188, "top": 411, "height": 21, "left": 129}, "words": "汉语拼音: Chongzu R"}, {"probability": {"variance": 0.006953, "average": 0.884672, "min": 0.801289}, "location": {"width": 117, "top": 413, "height": 17, "left": 411}, "words": " Cijiyinzi Zhuche"}, {"probability": {"variance": 0, "average": 0.998348, "min": 0.998099}, "location": {"width": 43, "top": 433, "height": 22, "left": 137}, "words": "成份"}, {"probability": {"variance": 0.000259, "average": 0.994824, "min": 0.893479}, "location": {"width": 956, "top": 456, "height": 25, "left": 132}, "words": "主要组成成份:重组人粒细胞刺激因子,本品系由高效表达人粒细胞刺激因子(简称人粒细胞刺激因子)基因的大肠"}, {"probability": {"variance": 3e-06, "average": 0.998692, "min": 0.994283}, "location": {"width": 584, "top": 479, "height": 24, "left": 129}, "words": "杆菌,经发酵、分离和高度纯化后获得的重组人粒细胞刺激因子制成"}, {"probability": {"variance": 1.6e-05, "average": 0.997944, "min": 0.983238}, "location": {"width": 443, "top": 503, "height": 23, "left": 130}, "words": "辅料名称:甘露醇;吐温-80;磷酸氢二钠;柠檬酸"}, {"probability": {"variance": 0, "average": 0.999539, "min": 0.999457}, "location": {"width": 42, "top": 526, "height": 22, "left": 138}, "words": "性状"}, {"probability": {"variance": 1e-06, "average": 0.999373, "min": 0.997807}, "location": {"width": 118, "top": 547, "height": 25, "left": 167}, "words": "无色透明液体"}, {"probability": {"variance": 9e-06, "average": 0.997533, "min": 0.993378}, "location": {"width": 64, "top": 572, "height": 23, "left": 136}, "words": "适应症"}, {"probability": {"variance": 0.000773, "average": 0.99339, "min": 0.843376}, "location": {"width": 919, "top": 595, "height": 27, "left": 166}, "words": "1.癌症化疗等原因导致中性粒细胞减少症;癌症患者使用骨髓抑制性化疗药物,特别在强烈的骨髓剥夺性化学"}, {"probability": {"variance": 3.1e-05, "average": 0.997553, "min": 0.963137}, "location": {"width": 952, "top": 620, "height": 24, "left": 130}, "words": "药物治疗后,注射本品有助于预防中性粒细胞减少症的发生,减轻中性粒细胞减少的程度,缩短粒细胞缺乏症的持"}, {"probability": {"variance": 3e-06, "average": 0.99914, "min": 0.991119}, "location": {"width": 543, "top": 643, "height": 23, "left": 131}, "words": "续时间,加速粒细胞数的恢复,从而减少合并感染发热的危险性"}, {"probability": {"variance": 0.017034, "average": 0.967132, "min": 0.429029}, "location": {"width": 333, "top": 665, "height": 24, "left": 167}, "words": "2促进骨髓移植后的中性粒细胞数升高"}, {"probability": {"variance": 0.007928, "average": 0.960618, "min": 0.717151}, "location": {"width": 207, "top": 691, "height": 21, "left": 168}, "words": "3.骨髓发育不良综合征引"}, {"probability": {"variance": 4.1e-05, "average": 0.997771, "min": 0.964676}, "location": {"width": 625, "top": 690, "height": 25, "left": 459}, "words": "粒细胞减少症,再生障碍性贫血引起的中性粒细胞减少症,先天性、特发性"}, {"probability": {"variance": 1e-06, "average": 0.99916, "min": 0.997476}, "location": {"width": 214, "top": 712, "height": 23, "left": 128}, "words": "中性粒细胞减少症,骨髓"}, {"probability": {"variance": 0.011996, "average": 0.964924, "min": 0.520971}, "location": {"width": 428, "top": 714, "height": 23, "left": 459}, "words": "征件中性粒细胞减少症,周期性中性粒细胞减少症"}, {"probability": {"variance": 0.038486, "average": 0.900286, "min": 0.386317}, "location": {"width": 160, "top": 738, "height": 21, "left": 136}, "words": "规格]6.0×10IU"}, {"probability": {"variance": 0.01344, "average": 0.935115, "min": 0.463758}, "location": {"width": 423, "top": 739, "height": 21, "left": 568}, "words": "(50μg):0.9ml/支;1.2×10IU(200μg):1.2ml/支"}, {"probability": {"variance": 0.014743, "average": 0.873822, "min": 0.630005}, "location": {"width": 60, "top": 762, "height": 17, "left": 252}, "words": "10TU(3"}, {"probability": {"variance": 0.000303, "average": 0.988333, "min": 0.953801}, "location": {"width": 89, "top": 783, "height": 23, "left": 128}, "words": "[用法用量"}, {"probability": {"variance": 0.000838, "average": 0.974147, "min": 0.926278}, "location": {"width": 57, "top": 807, "height": 21, "left": 169}, "words": "1.肿瘤"}, {"probability": {"variance": 3e-06, "average": 0.997963, "min": 0.995714}, "location": {"width": 134, "top": 830, "height": 22, "left": 171}, "words": "用于化疗所致的"}, {"probability": {"variance": 0.006137, "average": 0.97425, "min": 0.545971}, "location": {"width": 684, "top": 828, "height": 26, "left": 385}, "words": "胞减少症等一成年患者化疗后,中性粒细胞数降至1000/mm3(白细胞计数200"}, {"probability": {"variance": 0.017781, "average": 0.940518, "min": 0.371138}, "location": {"width": 910, "top": 851, "height": 36, "left": 160}, "words": ")以下者,在开始后2-5gkg白次皮下或静脉注射给药。儿童患者化疗后中性粒细胞数降至50"}, {"probability": {"variance": 3.3e-05, "average": 0.993808, "min": 0.982267}, "location": {"width": 150, "top": 876, "height": 22, "left": 131}, "words": "mm3(白细胞计数"}, {"probability": {"variance": 0.00272, "average": 0.976654, "min": 0.799932}, "location": {"width": 304, "top": 901, "height": 21, "left": 129}, "words": "数回升至5000/mm3(白细胞计数10"}, {"probability": {"variance": 6.7e-05, "average": 0.994657, "min": 0.976392}, "location": {"width": 195, "top": 901, "height": 21, "left": 496}, "words": "m3)以上时,停止给药"}, {"probability": {"variance": 0.014398, "average": 0.963039, "min": 0.565075}, "location": {"width": 212, "top": 923, "height": 22, "left": 164}, "words": "2.急性白血病化疗所致的"}, {"probability": {"variance": 0.016231, "average": 0.968695, "min": 0.428236}, "location": {"width": 362, "top": 923, "height": 22, "left": 460}, "words": "减少症白血病患者化疗后白细胞计数不足"}, {"probability": {"variance": 0.000132, "average": 0.99307, "min": 0.958301}, "location": {"width": 210, "top": 922, "height": 27, "left": 876}, "words": "mm3,骨髓中的原粒细胞"}, {"probability": {"variance": 0.00439, "average": 0.980355, "min": 0.646519}, "location": {"width": 941, "top": 945, "height": 26, "left": 129}, "words": "明显减少,外周血液中未见原粒细胞的情况下,成年患者2-5μg/kg每日1次皮下或静脉注射给药;儿童患者2g"}, {"probability": {"variance": 0.000902, "average": 0.98881, "min": 0.866996}, "location": {"width": 507, "top": 972, "height": 21, "left": 130}, "words": "kg每日1次皮下或静脉注射给药。当中性粒细胞数回升至50"}, {"probability": {"variance": 0.000262, "average": 0.9906, "min": 0.948024}, "location": {"width": 133, "top": 973, "height": 20, "left": 691}, "words": "m3(白细胞计数"}, {"probability": {"variance": 0.007774, "average": 0.961759, "min": 0.716809}, "location": {"width": 159, "top": 972, "height": 24, "left": 924}, "words": "3)以上时,停止给"}, {"probability": {"variance": 0, "average": 0.999985, "min": 0.999985}, "location": {"width": 22, "top": 996, "height": 20, "left": 126}, "words": "药"}, {"probability": {"variance": 0.004426, "average": 0.982924, "min": 0.534274}, "location": {"width": 919, "top": 1017, "height": 26, "left": 165}, "words": "3骨髓增生异常综合征伴中性粒细胞减少症成年患者在其中性粒细胞不足1000/mm3时,2~5μg/kg每日1次"}, {"probability": {"variance": 0.0002, "average": 0.993132, "min": 0.934773}, "location": {"width": 402, "top": 1040, "height": 24, "left": 126}, "words": "皮下或静脉注射给药。中性粒细胞数回升至500"}, {"probability": {"variance": 6.5e-05, "average": 0.996444, "min": 0.975211}, "location": {"width": 155, "top": 1039, "height": 25, "left": 594}, "words": "以上时,停止给药"}, {"probability": {"variance": 0.004507, "average": 0.983283, "min": 0.640239}, "location": {"width": 899, "top": 1063, "height": 28, "left": 184}, "words": "再生障碍性贫血所致中性粒细胞减少成年患者在其中性粒细胞低于1000/mm3时,2-5ug/kg每日1次皮下"}, {"probability": {"variance": 4e-05, "average": 0.996721, "min": 0.963751}, "location": {"width": 680, "top": 1087, "height": 24, "left": 129}, "words": "或静脉注射给药。中性粒细胞数回升至5000/mm3以上时,酌情减量或停止给药"}, {"probability": {"variance": 0.00454, "average": 0.989176, "min": 0.522501}, "location": {"width": 919, "top": 1111, "height": 24, "left": 164}, "words": "5.周期性中性粒细胞减少症、自身免疫性中性粒细胞减少症和慢性中性粒细胞减少症成年患者中性粒细胞低于"}, {"probability": {"variance": 0.002539, "average": 0.976274, "min": 0.737144}, "location": {"width": 950, "top": 1133, "height": 26, "left": 133}, "words": "000/mm3时,1μg/kg每日1次皮下或静脉注射给药。儿童患者中性粒细胞低于1000/mm3时,1μg/kg每日1次"}, {"probability": {"variance": 0.00015, "average": 0.994243, "min": 0.938339}, "location": {"width": 719, "top": 1157, "height": 24, "left": 127}, "words": "皮下或静脉注射给药。中性粒细胞数回升至5000/mm3以上时,酌情减量或停止给药"}, {"probability": {"variance": 0.002273, "average": 0.986526, "min": 0.749101}, "location": {"width": 919, "top": 1180, "height": 25, "left": 163}, "words": "6.用于促进骨髓移植患者中性粒细胞增加成人在骨髓移植的第2日至第5日开始用药,2~5μg/kg每日1次皮"}, {"probability": {"variance": 0.000546, "average": 0.990581, "min": 0.864136}, "location": {"width": 952, "top": 1203, "height": 27, "left": 131}, "words": "下或静脉注射给药。儿童在骨髓移植的第2日至第5日开始用药,2μg/kg每日1次皮下或静脉注射给药。中性粒"}, {"probability": {"variance": 0.001462, "average": 0.990026, "min": 0.762036}, "location": {"width": 584, "top": 1227, "height": 24, "left": 127}, "words": "细胞回升至5000/mm3(白细胞计数10000/mm3)以上时,停止给药"}, {"probability": {"variance": 3e-06, "average": 0.998907, "min": 0.995207}, "location": {"width": 88, "top": 1252, "height": 21, "left": 128}, "words": "[不良反应"}, {"probability": {"variance": 1.7e-05, "average": 0.998386, "min": 0.977066}, "location": {"width": 547, "top": 1273, "height": 24, "left": 163}, "words": "1.肌肉骨骼系统:有时会有肌肉酸痛、骨痛、腰痛、胸痛的现象"}, {"probability": {"variance": 3e-06, "average": 0.998722, "min": 0.991821}, "location": {"width": 662, "top": 1297, "height": 26, "left": 185}, "words": "消化系统:有时会出现食欲不振的现象,或肝脏谷丙转氨酶、谷草转氨酶升高"}, {"probability": {"variance": 0.001681, "average": 0.989129, "min": 0.776285}, "location": {"width": 533, "top": 1322, "height": 22, "left": 185}, "words": "其他:有人会出现发热、头疼、乏力及皮疹,ALP、LDH升高"}, {"probability": {"variance": 0.001398, "average": 0.989384, "min": 0.788464}, "location": {"width": 627, "top": 1344, "height": 25, "left": 183}, "words": "极少数人会出现休克、间质性肺炎、成人呼吸窘迫综合征、幼稚细胞增加"}, {"probability": {"variance": 0, "average": 0.999783, "min": 0.999607}, "location": {"width": 43, "top": 1368, "height": 23, "left": 134}, "words": "禁忌"}, {"probability": {"variance": 1.1e-05, "average": 0.997824, "min": 0.984709}, "location": {"width": 591, "top": 1391, "height": 23, "left": 178}, "words": "对粒细胞刺激因子过敏者以及对大肠杆菌表达的其他制剂过敏者禁用"}, {"probability": {"variance": 3e-06, "average": 0.998854, "min": 0.992716}, "location": {"width": 310, "top": 1414, "height": 24, "left": 185}, "words": "严重肝、肾、心、肺功能障碍者禁用"}, {"probability": {"variance": 2e-06, "average": 0.99883, "min": 0.994079}, "location": {"width": 836, "top": 1438, "height": 25, "left": 184}, "words": "骨髓中幼稚粒细胞未显著减少的骨髓性白血病患者或外周血中检出幼稚粒细胞的骨髓性白血病患者"}, {"probability": {"variance": 0, "average": 0.999781, "min": 0.999336}, "location": {"width": 83, "top": 1461, "height": 22, "left": 132}, "words": "注意事项"}, {"probability": {"variance": 0.001284, "average": 0.991172, "min": 0.819513}, "location": {"width": 434, "top": 1484, "height": 23, "left": 186}, "words": "本品应在化疗药物给药结束后24~48小时开始使用"}, {"probability": {"variance": 1.3e-05, "average": 0.997595, "min": 0.981509}, "location": {"width": 663, "top": 1508, "height": 25, "left": 181}, "words": "使用本品过程中应定期每周监测血象2次,特别是中性粒细胞数目变化的情况"}, {"probability": {"variance": 0.000641, "average": 0.993939, "min": 0.851115}, "location": {"width": 626, "top": 1530, "height": 24, "left": 162}, "words": "3.对髓性细胞系统的恶性增殖(急性粒细胞性白血病等)本品应慎重使用"}, {"probability": {"variance": 1.5e-05, "average": 0.997996, "min": 0.979049}, "location": {"width": 901, "top": 1554, "height": 25, "left": 181}, "words": "长期使用本品的安全有效性尚未建立,曾有报导可见脾脏增大。虽然本品临床试验未发生过敏反应病例,但"}, {"probability": {"variance": 6.7e-05, "average": 0.996633, "min": 0.958783}, "location": {"width": 958, "top": 1577, "height": 27, "left": 124}, "words": "国外同类制剂曾发生少数过敏反应(发生率<1/4000),可表现为皮疹、荨麻疹、颜面浮肿、呼吸困难、心动过速"}, {"probability": {"variance": 9e-06, "average": 0.998278, "min": 0.98228}, "location": {"width": 962, "top": 1599, "height": 32, "left": 122}, "words": "及低血压,多在使用本品30分钟内发生,应立即停用,经抗组织胺、皮质激素、支气管解痉剂和(或)肾上腺素"}, {"probability": {"variance": 3.8e-05, "average": 0.998263, "min": 0.967577}, "location": {"width": 506, "top": 1625, "height": 23, "left": 124}, "words": "等处理后症状能迅速消失。这些病例不应再次使用致敏药物"}, {"probability": {"variance": 0.001557, "average": 0.98758, "min": 0.845367}, "location": {"width": 255, "top": 1649, "height": 22, "left": 161}, "words": "5.本品仅供在医生指导下使用"}], "language": 3}